Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-26-001066·Tango Therapeutics, Inc.
Schedule 13G ownership disclosure
Tango Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 87583X109
Event date: 2025-12-31
- Filing-level shares
- 10,072,225.00
- Percent of class
- 7.5%
- Woodline Partners LP
Shares: 10,072,225.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001066
- Form type
- SCHEDULE 13G/A
- Filer
- Tango Therapeutics, Inc.
- CIK
- CIK 1819133
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership